Efficacy and Safety Data on Novel Oral Proprotein Convertase Subtilisin-Kexin Type 9 Antagonist

Rangrez, Ashraf Y. and Borlepawar, Ankush and Schmiedel, Nesrin and Deshpande, Anushka and Christen, Lynn and Bernt, Alexander and Kumari, Manju and Remes, Anca and Helbig, Andreas and Jungmann, Andreas and Sossalla, Samuel T. and Tholey, Andreas and Mueller, Oliver J. and Frank, Derk and Frey, Norbert (2019) Efficacy and Safety Data on Novel Oral Proprotein Convertase Subtilisin-Kexin Type 9 Antagonist. CIRCULATION RESEARCH, 125 (12). E110-E110. ISSN 0009-7330, 1524-4571

Full text not available from this repository.
Item Type: Article
Uncontrolled Keywords: Hypertrophic cardiomyopathy; Inflammation; Ubiquitin
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Innere Medizin II
Depositing User: Dr. Gernot Deinzer
Date Deposited: 20 Mar 2020 08:08
Last Modified: 20 Mar 2020 08:08
URI: https://pred.uni-regensburg.de/id/eprint/25685

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.